{"id":"W2922280445","doi":"10.1002/art.40866","title":"A Fifty‐Two–Week, Randomized, Placebo‐Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis","year":2019,"lang":"en","type":"article","venue":"Arthritis & Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network; University of Alberta","funders":"UCB Pharma; Pfizer; Eli Lilly and Company; Amgen","keywords":"Certolizumab pegol; Medicine; Placebo; Clinical endpoint; Internal medicine; Ankylosing spondylitis; Randomized controlled trial; Axial spondyloarthritis; Surgery; Physical therapy; Disease; Sacroiliitis; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004394317,0.0005894415,0.005135606,0.0009058531,0.0001172956,0.00002555305,0.000217047,0.0003495237,0.001369043],"category_scores_gemma":[0.0006773022,0.0005379996,0.00117175,0.0006484305,0.0006763113,0.0001772948,0.0001305678,0.000460999,0.0002996945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007481099,"about_ca_system_score_gemma":0.0002051478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001526428,"about_ca_topic_score_gemma":0.002096349,"domain_scores_codex":[0.9948992,0.000668656,0.002004872,0.0008678493,0.0005599849,0.0009994619],"domain_scores_gemma":[0.9969825,0.001279051,0.0005521236,0.0007585039,0.000189194,0.0002386045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9504664,0.00164973,0.0283043,0.00009578326,0.0008098974,0.001969445,0.0006301585,0.000002730262,0.00008714115,0.005201051,0.0001645052,0.01061887],"study_design_scores_gemma":[0.9854933,0.003364689,0.0009283466,0.0009860083,0.0001818137,0.006621218,0.0002497805,0.0001262167,0.00007936031,0.0007727591,0.0007926087,0.0004039182],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9666315,0.01469046,0.000009978071,0.001070519,0.00179905,0.008629282,0.00004241073,0.0001025331,0.007024261],"genre_scores_gemma":[0.9832115,0.01430228,0.0003312421,0.00007183209,0.00007397176,0.001537396,0.00007778767,0.00007429207,0.0003197031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03502689,"threshold_uncertainty_score":0.9997072,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007715533130576363,"score_gpt":0.2472922794934098,"score_spread":0.2395767463628334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}